On November 19, 2018 Bausch Health Companies Inc. (NYSE/TSX: BHC) reported that the company will participate in three upcoming investor conferences (Press release, Valeant, NOV 19, 2018, View Source [SID1234531479]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Joseph C. Papa, chairman and chief executive officer, is scheduled to participate at the 30th Annual Piper Jaffray Healthcare Conference in New York on Nov. 27, 2018 at 10:30 a.m. ET.

Paul S. Herendeen, executive vice president and chief financial officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Evercore ISI HealthconX Conference on Nov. 28, 2018 in Boston at 3:30 p.m. ET.

Paul S. Herendeen, executive vice president and chief financial officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the 2018 Citi Global Healthcare Conference on Dec. 5, 2018 in New York at 8:45 a.m. ET.

Live webcasts and audio archives of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. web site at: View Source